Japan materials group Toray Industries will apply this year for fast-track government approval to sell a cancer screening test that requires only one drop of blood.
Life Science & Medical Technology
Ahead of World No Tobacco Day on Friday, smokers who have been fighting a lonely battle against nicotine addiction were given another option in their quest to kick the habit.
Japan's national medical insurance system was given the go-ahead on Wednesday to cover leukemia treatment using expensive Kymriah from Swiss drugmaker Novartis.
Takeda Pharmaceutical CEO Christophe Weber promised greater cost savings from the company's purchase of Irish drugmaker Shire, lifting the savings target by 43% versus its earlier forecast.
Takeda Pharmaceutical on Thursday said it will sell its dry-eye drug business to Swiss rival Novartis for up to $5.3 billion.
Nippon Telegraph and Telephone will launch a preventive medicine business as early as 2020, Nikkei has learned.
A Saga University research team is aiming to start in summer of this year at the earliest a clinical study involving the transplantation of blood vessels made with a three-dimensional bioprinter into patients receiving hemodialysis.
Science has Dr. Masayo Takahashi’s mother to thank, in a way, for some of the most notable developments in regenerative medicine using stem cells.
A Japanese team reported Thursday that five patients with a severe eye disease were doing well after they received in 2017 the world’s first transplant surgeries using induced pluripotent stem cells, known as iPS cells, from donors.
Japan plans to create a law to restrict gene editing of fertilized human eggs to basic research and ban such eggs from being returned to the uterus, sources close to the matter said Friday.